BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11096075)

  • 1. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest.
    Manni I; Mazzaro G; Gurtner A; Mantovani R; Haugwitz U; Krause K; Engeland K; Sacchi A; Soddu S; Piaggio G
    J Biol Chem; 2001 Feb; 276(8):5570-6. PubMed ID: 11096075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
    Müller GA; Heissig F; Engeland K
    Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter.
    Wasner M; Haugwitz U; Reinhard W; Tschöp K; Spiesbach K; Lorenz J; Mössner J; Engeland K
    Gene; 2003 Jul; 312():225-37. PubMed ID: 12909359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
    Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
    Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
    Innocente SA; Lee JM
    FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chk1 instability is coupled to mitotic cell death of p53-deficient cells in response to virus-induced DNA damage signaling.
    Jurvansuu J; Fragkos M; Ingemarsdotter C; Beard P
    J Mol Biol; 2007 Sep; 372(2):397-406. PubMed ID: 17663993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-Y binds to both G1- and G2-specific cyclin promoters; a possible role in linking CDK2/Cyclin A to CDK1/Cyclin B.
    Chae HD; Kim J; Shin DY
    BMB Rep; 2011 Aug; 44(8):553-7. PubMed ID: 21871181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.
    Hu Q; Lu JF; Luo R; Sen S; Maity SN
    Nucleic Acids Res; 2006; 34(21):6272-85. PubMed ID: 17098936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single cell cycle genes homology region (CHR) controls cell cycle-dependent transcription of the cdc25C phosphatase gene and is able to cooperate with E2F or Sp1/3 sites.
    Haugwitz U; Wasner M; Wiedmann M; Spiesbach K; Rother K; Mössner J; Engeland K
    Nucleic Acids Res; 2002 May; 30(9):1967-76. PubMed ID: 11972334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73.
    Krause K; Haugwitz U; Wasner M; Wiedmann M; Mössner J; Engeland K
    Biochem Biophys Res Commun; 2001 Jun; 284(3):743-50. PubMed ID: 11396965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
    Wilson DW; Lamé MW; Dunston SK; Segall HJ
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):69-80. PubMed ID: 10896848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of cyclin B1 gene transcription in terminally differentiated skeletal muscle cells is associated with loss of functional CCAAT-binding NF-Y complex.
    Farina A; Manni I; Fontemaggi G; Tiainen M; Cenciarelli C; Bellorini M; Mantovani R; Sacchi A; Piaggio G
    Oncogene; 1999 May; 18(18):2818-27. PubMed ID: 10362252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
    Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
    Tran T; Kolupaeva V; Basilico C
    Cell Cycle; 2010 Nov; 9(21):4379-86. PubMed ID: 21051949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
    Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
    Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.
    St Clair S; Giono L; Varmeh-Ziaie S; Resnick-Silverman L; Liu WJ; Padi A; Dastidar J; DaCosta A; Mattia M; Manfredi JJ
    Mol Cell; 2004 Dec; 16(5):725-36. PubMed ID: 15574328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of CDC25C by AMP-activated protein kinase mediates a metabolic checkpoint during cell-cycle G
    Shen Y; Sherman JW; Chen X; Wang R
    J Biol Chem; 2018 Apr; 293(14):5185-5199. PubMed ID: 29467227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
    J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53.
    Chae HD; Yun J; Shin DY
    Exp Mol Med; 2005 Oct; 37(5):488-91. PubMed ID: 16264274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress.
    Charrier-Savournin FB; Château MT; Gire V; Sedivy J; Piette J; Dulic V
    Mol Biol Cell; 2004 Sep; 15(9):3965-76. PubMed ID: 15181148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.